Concepedia

Publication | Open Access

Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials

DOIFull Paper Access

60

Citations

44

References

2014

Year

Nayyar Iqbal, Artist Parker, Robert Frederich, Mark Donovan, Boaz Hirshberg
Cardiovascular Diabetology

Abstract

Analysis of pooled data from 20 clinical trials in patients with T2DM suggests that saxagliptin is not associated with an increased CV risk.

References

YearCitations

Page 1